Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

400 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Health-related quality of life in men with oligometastatic prostate cancer following metastases-directed stereotactic body radiotherapy: Real-world data from the E2-RADIatE OligoCare cohort.
Bultijnck R, Van Hemelrijck M, Fonteyne V, Livi L, Jereczek-Fossa BA, Hemmatazad H, Mayinger M, Peulen H, Verbeke L, Ramella S, Castro P, Tsoutsou P, Stellamans K, Shaukat A, Orazem M, Jeene P, Braam P, Verkooijen H, Simek IM, Alongi F, Clementel E, Fortpied C, Machingura A, Boakye Oppong F, Guckenberger M, Ost P. Bultijnck R, et al. Among authors: van hemelrijck m. Clin Transl Radiat Oncol. 2023 Dec 29;45:100715. doi: 10.1016/j.ctro.2023.100715. eCollection 2024 Mar. Clin Transl Radiat Oncol. 2023. PMID: 38274388 Free PMC article.
Defining the role of real-world data in cancer clinical research: The position of the European Organisation for Research and Treatment of Cancer.
Saesen R, Van Hemelrijck M, Bogaerts J, Booth CM, Cornelissen JJ, Dekker A, Eisenhauer EA, Freitas A, Gronchi A, Hernán MA, Hulstaert F, Ost P, Szturz P, Verkooijen HM, Weller M, Wilson R, Lacombe D, van der Graaf WT. Saesen R, et al. Among authors: van hemelrijck m, van der graaf wt. Eur J Cancer. 2023 Jun;186:52-61. doi: 10.1016/j.ejca.2023.03.013. Epub 2023 Mar 21. Eur J Cancer. 2023. PMID: 37030077 Free article.
The current use of the EORTC QLQ-NMIBC24 and QLQ-BLM30 questionnaires for the assessment of health-related quality of life in bladder cancer patients: a systematic review.
Rammant E, Fox L, Beyer K, Aaronson NK, Chaloner R, De Padova S, Liedberg F, Wintner LM, Decaestecker K, Fonteyne V, Perdek N, Wylie H, Catto JWF, Ripping TM, Holzner B, Van Leeuwen M, Van Hemelrijck M; EORTC Quality of Life Group. Rammant E, et al. Among authors: van hemelrijck m, van leeuwen m. Qual Life Res. 2023 Aug;32(8):2127-2135. doi: 10.1007/s11136-022-03335-4. Epub 2023 Jan 17. Qual Life Res. 2023. PMID: 36648569 Review.
Survivorship Data in Prostate Cancer: Where Are We and Where Do We Need To Be?
Russell B, Beyer K, Lawlor A, Roobol MJ, Venderbos LDF, Remmers S, Briers E, MacLennan SJ, MacLennan S, Omar MI, Van Hemelrijck M; PIONEER Consortium. Russell B, et al. Among authors: van hemelrijck m. Eur Urol Open Sci. 2023 Dec 19;59:27-29. doi: 10.1016/j.euros.2023.11.004. eCollection 2024 Jan. Eur Urol Open Sci. 2023. PMID: 38298764 Free PMC article.
A Systematic Review to Evaluate Patient-Reported Outcome Measures (PROMs) for Metastatic Prostate Cancer According to the COnsensus-Based Standard for the Selection of Health Measurement INstruments (COSMIN) Methodology.
Ratti MM, Gandaglia G, Sisca ES, Derevianko A, Alleva E, Beyer K, Moss C, Barletta F, Scuderi S, Omar MI, MacLennan S, Williamson PR, Zong J, MacLennan SJ, Mottet N, Cornford P, Aiyegbusi OL, Van Hemelrijck M, N'Dow J, Briganti A. Ratti MM, et al. Among authors: van hemelrijck m. Cancers (Basel). 2022 Oct 19;14(20):5120. doi: 10.3390/cancers14205120. Cancers (Basel). 2022. PMID: 36291905 Free PMC article. Review.
Reasons for Discontinuing Active Surveillance: Assessment of 21 Centres in 12 Countries in the Movember GAP3 Consortium.
Van Hemelrijck M, Ji X, Helleman J, Roobol MJ, van der Linden W, Nieboer D, Bangma CH, Frydenberg M, Rannikko A, Lee LS, Gnanapragasam VJ, Kattan MW; Members of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance GAP3 consortium; Members of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance GAP3 consortium. Van Hemelrijck M, et al. Among authors: van der linden w. Eur Urol. 2019 Mar;75(3):523-531. doi: 10.1016/j.eururo.2018.10.025. Epub 2018 Oct 29. Eur Urol. 2019. PMID: 30385049 Free PMC article.
A Systematic Review of Heterogeneity in Outcome Definition and Reporting in Localised Renal Cancer.
Beyer K, Widdershoven C, Wintner LM, Dabestani S, Marconi L, Moss C, Kinsella N, Yuan Y, Giles RH, Barod R, Van Hemelrijck M, Bex A, Zondervan P, MacLennan S. Beyer K, et al. Among authors: van hemelrijck m. Eur Urol Open Sci. 2022 Dec 15;48:1-11. doi: 10.1016/j.euros.2022.11.014. eCollection 2023 Feb. Eur Urol Open Sci. 2022. PMID: 36578462 Free PMC article. Review.
Research protocol to identify progression and death amongst patients with metastatic hormone-sensitive prostate cancer treated with available treatments: PIONEER IMI's "big data for better outcomes" program.
Gomez Rivas J, Nicoletti R, Ibáñez L, Steinbeisser C, de Meulder B, Golozar A, Axelsson SE, Snijder R, Bjartell A, Cornford P, Van Hemelrijck M, Beyer K, Willemse PP, Murtola T, Roobol MJ, Moreno-Sierra J, Campi R, Gacci M, Mottet N, Merseburger A, Ndow J. Gomez Rivas J, et al. Among authors: van hemelrijck m. Int J Surg Protoc. 2023 Oct 17;27(3):122-129. doi: 10.1097/SP9.0000000000000009. eCollection 2023 Dec. Int J Surg Protoc. 2023. PMID: 38046899 Free PMC article.
Unanswered questions in prostate cancer - findings of an international multi-stakeholder consensus by the PIONEER consortium.
Omar MI, MacLennan S, Ribal MJ, Roobol MJ, Dimitropoulos K, van den Broeck T, MacLennan SJ, Axelsson SE, Gandaglia G, Willemse PP, Mastris K, Ransohoff JB, Devecseri Z, Abbott T, De Meulder B, Bjartell A, Asiimwe A, N'Dow J; PIONEER Consortium. Omar MI, et al. Nat Rev Urol. 2023 Aug;20(8):494-501. doi: 10.1038/s41585-023-00748-9. Epub 2023 Apr 3. Nat Rev Urol. 2023. PMID: 37012441 Review.
400 results